Skip to main content
Top
Published in: Clinical Orthopaedics and Related Research® 5/2012

01-05-2012 | Clinical Research

High Rate of Infection Control with One-stage Revision of Septic Knee Prostheses Excluding MRSA and MRSE

Authors: Joachim Singer, MD, Andreas Merz, MD, Lars Frommelt, MD, Bernd Fink, MD

Published in: Clinical Orthopaedics and Related Research® | Issue 5/2012

Login to get access

Abstract

Background

The rate of infection control for one-stage revision of infected knee arthroplasties is unclear as are the factors influencing infection control. Such factors include duration of infection and the type of infected prosthesis.

Questions/purposes

We therefore determined: (1) the rate of infection control with one-stage revision of septic knee prostheses, (2) the clinical knee scores that can be achieved, (3) whether the duration of infection or the type of prosthesis influence the level of infection control, and (4) whether different types of prostheses influence the knee scores.

Methods

We retrospectively reviewed prospectively collected data from 63 patients who underwent one-stage revisions of septic knee endoprostheses (six unicondylar, 37 primary total knee replacement prostheses, and 20 hinged knee endoprostheses) between 2004 and 2006. All were treated locally and systemically with microorganism-specific antibiotics. For this study we excluded patients with Methicillin-resistant Staphylococcus aureus and Methicillin-resistant Staphylococcus epidermidis or unknown microorganisms. The patients were examined for infection every 3 months and Oxford and Knee Society scores were assessed at the same time. The minimum followup was 24 months (mean followup, 36 months; range, 24–70 months).

Results

None of the patients with replacement unicondylar and primary total knee replacement prostheses had recurrence of infection. Three of the 20 patients with the hinged infected knee prostheses had recurrences; these three patients had chronic infections and had undergone two to three revision operations during at least a 5-year period. The likelihood of infection control was influenced by the duration of infection. The mean Knee Society knee score 24 months after surgery was 72 points (range, 20–98 points), the Knee Society function score was 71 points (range, 10–100 points), and the Oxford-12 knee score was 27 points (range, 13–44 points).

Conclusions

One-stage revision of septic knee prostheses achieved an infection control rate of 95% and higher knee scores than reported for two-stage revisions. Higher rates of recurrent infection appeared to be associated with long-term chronic infections of hinged prostheses.
Literature
1.
go back to reference Anagnostakos K, Kelm J, Regitz T, Schmitt E, Jung W. In vitro evaluation of antibiotic release from and bacteria growth inhibition by antibiotic-loaded acrylic bone cement spacers. J Biomed Mater Res B Appl Biomater. 2005;72:373–378.PubMed Anagnostakos K, Kelm J, Regitz T, Schmitt E, Jung W. In vitro evaluation of antibiotic release from and bacteria growth inhibition by antibiotic-loaded acrylic bone cement spacers. J Biomed Mater Res B Appl Biomater. 2005;72:373–378.PubMed
2.
go back to reference Baleani M, Persson C, Zolezzi C, Andollina A, Borelli AM, Tigani D. Biological and biomechanical effects of vancomycin and meropenem in acrylic bone cement. J Arthroplasty. 2008;23:1232–1238.PubMedCrossRef Baleani M, Persson C, Zolezzi C, Andollina A, Borelli AM, Tigani D. Biological and biomechanical effects of vancomycin and meropenem in acrylic bone cement. J Arthroplasty. 2008;23:1232–1238.PubMedCrossRef
3.
go back to reference Barrack RL, Engh G, Rorabeck C, Sawhney J, Woolfrey M. Patient satisfaction and outcome after septic versus aseptic revision total knee arthroplasty. J Arthroplasty. 2000;15:990–993.PubMedCrossRef Barrack RL, Engh G, Rorabeck C, Sawhney J, Woolfrey M. Patient satisfaction and outcome after septic versus aseptic revision total knee arthroplasty. J Arthroplasty. 2000;15:990–993.PubMedCrossRef
4.
go back to reference Bengtson S, Knutson K. The infected knee arthroplasty: a 6-year follow-up of 357 cases. Acta Orthop Scand. 1991;62:301–311.PubMedCrossRef Bengtson S, Knutson K. The infected knee arthroplasty: a 6-year follow-up of 357 cases. Acta Orthop Scand. 1991;62:301–311.PubMedCrossRef
5.
go back to reference Bertazonni Minelli E, Benini A, Magnan B, Bartolozzi P. Release of gentamicin and vancomycin from temporary human hip spacers in two-stage revision of infected arthroplasty. J Antimicrob Chemother. 2004;53:329–334.CrossRef Bertazonni Minelli E, Benini A, Magnan B, Bartolozzi P. Release of gentamicin and vancomycin from temporary human hip spacers in two-stage revision of infected arthroplasty. J Antimicrob Chemother. 2004;53:329–334.CrossRef
6.
go back to reference Buechel FF, Femino FP, D’Alessio J. Primary exchange revision arthroplasty for infected total knee replacement: a long-term study. Am J Orthop (Belle Mead NJ). 2004;33:190–198; discussion 198. Buechel FF, Femino FP, D’Alessio J. Primary exchange revision arthroplasty for infected total knee replacement: a long-term study. Am J Orthop (Belle Mead NJ). 2004;33:190–198; discussion 198.
7.
go back to reference Calton TF, Fehring TK, Griffin WL. Bone loss associated with the use of spacer blocks in infected total knee arthroplasty. Clin Orthop Relat Res. 1997;345:148–154.PubMedCrossRef Calton TF, Fehring TK, Griffin WL. Bone loss associated with the use of spacer blocks in infected total knee arthroplasty. Clin Orthop Relat Res. 1997;345:148–154.PubMedCrossRef
8.
go back to reference Cameron HU, Hu C, Vyamont D. Hinge total knee replacement revisited. Can J Surg. 1997;40:278–283.PubMed Cameron HU, Hu C, Vyamont D. Hinge total knee replacement revisited. Can J Surg. 1997;40:278–283.PubMed
9.
go back to reference Cierny G 3rd, DiPasquale D. Periprosthetic total joint infections: staging, treatment, and outcomes. Clin Orthop Relat Res. 2002;403:23–28.PubMedCrossRef Cierny G 3rd, DiPasquale D. Periprosthetic total joint infections: staging, treatment, and outcomes. Clin Orthop Relat Res. 2002;403:23–28.PubMedCrossRef
10.
go back to reference Cordero-Ampuero J, Esteban J, Garcia-Rey E. Results after late polymicrobial, gram-negative, and methicillin-resistant infections in knee arthroplasty. Clin Orthop Relat Res. 2010;468:1229–1236.PubMedCrossRef Cordero-Ampuero J, Esteban J, Garcia-Rey E. Results after late polymicrobial, gram-negative, and methicillin-resistant infections in knee arthroplasty. Clin Orthop Relat Res. 2010;468:1229–1236.PubMedCrossRef
11.
go back to reference Costerton JW. Biofilm theory can guide the treatment of device-related orthopaedic infections. Clin Orthop Relat Res. 2005;437:7–11.PubMedCrossRef Costerton JW. Biofilm theory can guide the treatment of device-related orthopaedic infections. Clin Orthop Relat Res. 2005;437:7–11.PubMedCrossRef
12.
go back to reference Cui Q, Mihalko WM, Shields JS, Ries M, Saleh KJ. Antibiotic-impregnated cement spacers for the treatment of infection associated with total hip or knee arthroplasty. J Bone Joint Surg Am. 2007;89:871–882.PubMedCrossRef Cui Q, Mihalko WM, Shields JS, Ries M, Saleh KJ. Antibiotic-impregnated cement spacers for the treatment of infection associated with total hip or knee arthroplasty. J Bone Joint Surg Am. 2007;89:871–882.PubMedCrossRef
13.
go back to reference Dawson J, Fitzpatrick R, Murray D, Carr A. Questionnaire on the perceptions of patients about total knee replacement. J Bone Joint Surg Br. 1998;80:63–69.PubMedCrossRef Dawson J, Fitzpatrick R, Murray D, Carr A. Questionnaire on the perceptions of patients about total knee replacement. J Bone Joint Surg Br. 1998;80:63–69.PubMedCrossRef
14.
go back to reference Ensing GT, van Horn JR, van der Mei HC, Busscher HJ, Neut D. Copal bone cement is more effective in preventing biofilm formation than Palacos R-G. Clin Orthop Relat Res. 2008;466:1492–1498.PubMedCrossRef Ensing GT, van Horn JR, van der Mei HC, Busscher HJ, Neut D. Copal bone cement is more effective in preventing biofilm formation than Palacos R-G. Clin Orthop Relat Res. 2008;466:1492–1498.PubMedCrossRef
15.
go back to reference Fehring TK, Griffin WL. Revision of failed cementless total knee implants with cement. Clin Orthop Relat Res. 1998;356:34–38.PubMedCrossRef Fehring TK, Griffin WL. Revision of failed cementless total knee implants with cement. Clin Orthop Relat Res. 1998;356:34–38.PubMedCrossRef
16.
go back to reference Fehring TK, Odum S, Calton TF, Mason JB. Articulating versus static spacers in revision total knee arthroplasty for sepsis: The Ranawat Award. Clin Orthop Relat Res. 2000;380:9–16.PubMedCrossRef Fehring TK, Odum S, Calton TF, Mason JB. Articulating versus static spacers in revision total knee arthroplasty for sepsis: The Ranawat Award. Clin Orthop Relat Res. 2000;380:9–16.PubMedCrossRef
17.
go back to reference Fink B, Grossmann A, Fuerst M, Schäfer P, Frommelt L. Two-stage cementless revision of infected hip endoprostheses. Clin Orthop Relat Res. 2009;467:1848–1858.PubMedCrossRef Fink B, Grossmann A, Fuerst M, Schäfer P, Frommelt L. Two-stage cementless revision of infected hip endoprostheses. Clin Orthop Relat Res. 2009;467:1848–1858.PubMedCrossRef
18.
go back to reference Fink B, Makowiak C, Fuerst M, Berger I, Schäfer P, Frommelt L. The value of synovial biopsy, joint aspiration, and C-reactive protein in the diagnosis of late peri-prosthetic infection of total knee replacements. J Bone Joint Surg Br. 2008;90:874–878.PubMedCrossRef Fink B, Makowiak C, Fuerst M, Berger I, Schäfer P, Frommelt L. The value of synovial biopsy, joint aspiration, and C-reactive protein in the diagnosis of late peri-prosthetic infection of total knee replacements. J Bone Joint Surg Br. 2008;90:874–878.PubMedCrossRef
19.
go back to reference Fink B, Vogt S, Reinsch M, Büchner H. Sufficient release of antibiotic by a spacer 6 weeks after implantation in two-stage revision of infected hip prostheses. Clin Orthop Relat Res. 2011; 469:3141–3147.PubMedCrossRef Fink B, Vogt S, Reinsch M, Büchner H. Sufficient release of antibiotic by a spacer 6 weeks after implantation in two-stage revision of infected hip prostheses. Clin Orthop Relat Res. 2011; 469:3141–3147.PubMedCrossRef
20.
go back to reference Freeman MG, Fehring TK, Odum SM, Fehring K, Griffin WL, Mason JB. Functional advantage of articulating versus static spacers in 2-stage revision for total knee arthroplasty infection. J Arthroplasty. 2007;22:1116–1121.PubMedCrossRef Freeman MG, Fehring TK, Odum SM, Fehring K, Griffin WL, Mason JB. Functional advantage of articulating versus static spacers in 2-stage revision for total knee arthroplasty infection. J Arthroplasty. 2007;22:1116–1121.PubMedCrossRef
21.
go back to reference Gallo J, Kolar M, Novotny R, Rihakova P, Ticha V. Pathogenesis of prosthesis-related infection. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2003;147:27–35.PubMed Gallo J, Kolar M, Novotny R, Rihakova P, Ticha V. Pathogenesis of prosthesis-related infection. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2003;147:27–35.PubMed
22.
go back to reference Ghanem E, Azzam K, Seeley M, Joshi A, Parvizi J. Staged revision for knee arthroplasty infection: what is the role of serologic tests before reimplantation? Clin Orthop Relat Res. 2009;467:1699–1705.PubMedCrossRef Ghanem E, Azzam K, Seeley M, Joshi A, Parvizi J. Staged revision for knee arthroplasty infection: what is the role of serologic tests before reimplantation? Clin Orthop Relat Res. 2009;467:1699–1705.PubMedCrossRef
23.
go back to reference Göksan SB, Freeman MA. One-stage reimplantation for infected total knee arthroplasty. J Bone Joint Surg Br. 1992;74:78–82.PubMed Göksan SB, Freeman MA. One-stage reimplantation for infected total knee arthroplasty. J Bone Joint Surg Br. 1992;74:78–82.PubMed
24.
go back to reference Goldman RT, Scuderi GR, Insall JN. 2-stage reimplantation for infected total knee replacement. Clin Orthop Relat Res. 1996;331:118–124.PubMedCrossRef Goldman RT, Scuderi GR, Insall JN. 2-stage reimplantation for infected total knee replacement. Clin Orthop Relat Res. 1996;331:118–124.PubMedCrossRef
25.
go back to reference Goldstein WM, Kopplin M, Wall R, Berland K. Temporary articulating methylmethacrylate antibiotic spacer (TAMMAS): a new method of intraoperative manufacturing of a custom articulating spacer. J Bone Joint Surg Am. 2001;83(suppl 2):92–97.PubMed Goldstein WM, Kopplin M, Wall R, Berland K. Temporary articulating methylmethacrylate antibiotic spacer (TAMMAS): a new method of intraoperative manufacturing of a custom articulating spacer. J Bone Joint Surg Am. 2001;83(suppl 2):92–97.PubMed
26.
go back to reference Gollwitzer H, Diehl P, Gerdesmeyer L, Mittelmeier W. [Diagnostic strategies in cases of suspected periprosthetic infection of the knee: a review of the literature and current recommendations][in German]. Orthopäde. 2006;35:904, 906–908, 910–916. Gollwitzer H, Diehl P, Gerdesmeyer L, Mittelmeier W. [Diagnostic strategies in cases of suspected periprosthetic infection of the knee: a review of the literature and current recommendations][in German]. Orthopäde. 2006;35:904, 906–908, 910–916.
27.
go back to reference Guenoun B, Latargez L, Freslon M, Defossez G, Salas N, Gayet LE. Complications following rotating hinge Endo-Modell (Link) knee arthroplasty. Orthop Traumatol Surg Res. 2009;95:529–536.PubMedCrossRef Guenoun B, Latargez L, Freslon M, Defossez G, Salas N, Gayet LE. Complications following rotating hinge Endo-Modell (Link) knee arthroplasty. Orthop Traumatol Surg Res. 2009;95:529–536.PubMedCrossRef
28.
go back to reference Haddad FS, Masri BA, Campbell D, McGraw RW, Beauchamp CP, Duncan CP. The PROSTALAC functional spacer in two-stage revision for infected knee replacements: prosthesis of antibiotic-loaded acrylic cement. J Bone Joint Surg Br. 2000;82:807–812.PubMedCrossRef Haddad FS, Masri BA, Campbell D, McGraw RW, Beauchamp CP, Duncan CP. The PROSTALAC functional spacer in two-stage revision for infected knee replacements: prosthesis of antibiotic-loaded acrylic cement. J Bone Joint Surg Br. 2000;82:807–812.PubMedCrossRef
29.
go back to reference Haleem AA, Berry DJ, Hanssen AD. Mid-term to long-term followup of two-stage reimplantation for infected total knee arthroplasty. Clin Orthop Relat Res. 2004;428:35–39.PubMedCrossRef Haleem AA, Berry DJ, Hanssen AD. Mid-term to long-term followup of two-stage reimplantation for infected total knee arthroplasty. Clin Orthop Relat Res. 2004;428:35–39.PubMedCrossRef
30.
go back to reference Hanssen AD, Spangehl MJ. Practical applications of antibiotic loaded bone cement for treatment of infected joint replacements. Clin Orthop Relat Res. 2004;427:79–85.PubMedCrossRef Hanssen AD, Spangehl MJ. Practical applications of antibiotic loaded bone cement for treatment of infected joint replacements. Clin Orthop Relat Res. 2004;427:79–85.PubMedCrossRef
31.
go back to reference Hirakawa K, Stulberg BN, Wilde AH, Bauer TW, Secic M. Results of 2-stage reimplantation for infected total knee arthroplasty. J Arthroplasty. 1998;13:22–28.PubMedCrossRef Hirakawa K, Stulberg BN, Wilde AH, Bauer TW, Secic M. Results of 2-stage reimplantation for infected total knee arthroplasty. J Arthroplasty. 1998;13:22–28.PubMedCrossRef
32.
go back to reference Hofmann AA, Kane KR, Tkach TK, Plaster RL, Camargo MP. Treatment of infected total knee arthroplasty using an articulating spacer. Clin Orthop Relat Res. 1995;321:45–54.PubMed Hofmann AA, Kane KR, Tkach TK, Plaster RL, Camargo MP. Treatment of infected total knee arthroplasty using an articulating spacer. Clin Orthop Relat Res. 1995;321:45–54.PubMed
33.
go back to reference Hsieh PH, Chang YH, Chen SH, Ueng SW, Shih CH. High concentration and bioactivity of vancomycin and aztreonam eluted from Simplex cement spacers in two-stage revision of infected hip implants: a study of 46 patients at an average follow-up of 107 days. J Orthop Res. 2006;24:1615–1621.PubMedCrossRef Hsieh PH, Chang YH, Chen SH, Ueng SW, Shih CH. High concentration and bioactivity of vancomycin and aztreonam eluted from Simplex cement spacers in two-stage revision of infected hip implants: a study of 46 patients at an average follow-up of 107 days. J Orthop Res. 2006;24:1615–1621.PubMedCrossRef
34.
go back to reference Huotari K, Lyytikäinen O; Hospital Infection Surveillance Team. Impact of postdischarge surveillance on the rate of surgical site infection after orthopedic surgery. Infect Control Hosp Epidemiol. 2006;27:1324–1329.PubMedCrossRef Huotari K, Lyytikäinen O; Hospital Infection Surveillance Team. Impact of postdischarge surveillance on the rate of surgical site infection after orthopedic surgery. Infect Control Hosp Epidemiol. 2006;27:1324–1329.PubMedCrossRef
35.
go back to reference Insall JN, Dorr LD, Scott RD, Scott WN. Rationale of the Knee Society clinical rating system. Clin Orthop Relat Res. 1989;248:13–14.PubMed Insall JN, Dorr LD, Scott RD, Scott WN. Rationale of the Knee Society clinical rating system. Clin Orthop Relat Res. 1989;248:13–14.PubMed
36.
go back to reference Jämsen E, Stogiannidis I, Malmivaara A, Pajamäki J, Puolakka T, Konttinen YT. Outcome of prosthesis exchange for infected knee arthroplasty: the effect of treatment approach. Acta Orthop. 2009;80:67–77.PubMedCrossRef Jämsen E, Stogiannidis I, Malmivaara A, Pajamäki J, Puolakka T, Konttinen YT. Outcome of prosthesis exchange for infected knee arthroplasty: the effect of treatment approach. Acta Orthop. 2009;80:67–77.PubMedCrossRef
37.
go back to reference Jämsen E, Varonen M, Huhtala H, Lehto MU, Lumio J, Konttinen YT, Moilanen T. Incidence of prosthetic joint infections after primary knee arthroplasty. J Arthroplasty. 2010;25:87–92.PubMedCrossRef Jämsen E, Varonen M, Huhtala H, Lehto MU, Lumio J, Konttinen YT, Moilanen T. Incidence of prosthetic joint infections after primary knee arthroplasty. J Arthroplasty. 2010;25:87–92.PubMedCrossRef
38.
go back to reference Kordelle J, Frommelt L, Klüber D, Seemann K. [Results of one-stage endoprosthesis revision in periprosthetic infection caused by methicillin-resistant Staphylococcus aureus][in German]. Z Orthop Ihre Grenzgeb. 2000;138:240–244.PubMedCrossRef Kordelle J, Frommelt L, Klüber D, Seemann K. [Results of one-stage endoprosthesis revision in periprosthetic infection caused by methicillin-resistant Staphylococcus aureus][in German]. Z Orthop Ihre Grenzgeb. 2000;138:240–244.PubMedCrossRef
39.
go back to reference Kurd MF, Ghanem E, Steinbrecher J, Parvizi J. Two-stage exchange knee arthroplasty: does resistance of the infecting organism influence the outcome? Clin Orthop Relat Res. 2010:468:2060–2066.PubMedCrossRef Kurd MF, Ghanem E, Steinbrecher J, Parvizi J. Two-stage exchange knee arthroplasty: does resistance of the infecting organism influence the outcome? Clin Orthop Relat Res. 2010:468:2060–2066.PubMedCrossRef
40.
go back to reference Lu H, Kou B, Lin J. [One-stage reimplantation for the salvage of total knee arthroplasty complicated by infection][in Chinese]. Zhonghua Wai Ke Za Zhi. 1997;35:456–458.PubMed Lu H, Kou B, Lin J. [One-stage reimplantation for the salvage of total knee arthroplasty complicated by infection][in Chinese]. Zhonghua Wai Ke Za Zhi. 1997;35:456–458.PubMed
41.
go back to reference Masri BA, Duncan CP, Beauchamp CP. Long-term elution of antibiotics from bone-cement: an in vivo study using the prosthesis of antibiotic-loaded acrylic cement (PROSTALAC) system. J Arthroplasty. 1998;13:331–338.PubMedCrossRef Masri BA, Duncan CP, Beauchamp CP. Long-term elution of antibiotics from bone-cement: an in vivo study using the prosthesis of antibiotic-loaded acrylic cement (PROSTALAC) system. J Arthroplasty. 1998;13:331–338.PubMedCrossRef
42.
go back to reference Meek RM, Masri BA, Dunlop D, Garbuz DS, Greidanus NV, McGraw R, Duncan CP. Patient satisfaction and functional status after treatment of infection at the site of a total knee arthroplasty with use of the PROSTALAC articulating spacer. J Bone Joint Surg Am. 2003;85:1888–1892.PubMedCrossRef Meek RM, Masri BA, Dunlop D, Garbuz DS, Greidanus NV, McGraw R, Duncan CP. Patient satisfaction and functional status after treatment of infection at the site of a total knee arthroplasty with use of the PROSTALAC articulating spacer. J Bone Joint Surg Am. 2003;85:1888–1892.PubMedCrossRef
43.
go back to reference Neut D, de Groot EP, Kowalski RS, van Horn JR, van der Mei HC, Busscher HJ. Gentamicin-loaded bone cement with clindamycin or fusidic acid added: biofilm formation and antibiotic release. J Biomed Mater Res A. 2005;73:165–170.PubMed Neut D, de Groot EP, Kowalski RS, van Horn JR, van der Mei HC, Busscher HJ. Gentamicin-loaded bone cement with clindamycin or fusidic acid added: biofilm formation and antibiotic release. J Biomed Mater Res A. 2005;73:165–170.PubMed
44.
go back to reference Neut D, van Horn JR, van Kooten TG, van der Mei HC, Busscher HJ. Detection of biomaterial-associated infections in orthopaedic joint implants. Clin Orthop Relat Res. 2003;413:261–268.PubMedCrossRef Neut D, van Horn JR, van Kooten TG, van der Mei HC, Busscher HJ. Detection of biomaterial-associated infections in orthopaedic joint implants. Clin Orthop Relat Res. 2003;413:261–268.PubMedCrossRef
45.
go back to reference Peersman G, Laskin R, Davis J, Peterson M. Infection in total knee replacement: a retrospective review of 6489 total knee replacements. Clin Orthop Relat Res. 2001;392:15–23.PubMedCrossRef Peersman G, Laskin R, Davis J, Peterson M. Infection in total knee replacement: a retrospective review of 6489 total knee replacements. Clin Orthop Relat Res. 2001;392:15–23.PubMedCrossRef
46.
go back to reference Penner MJ, Masri BA, Duncan CP. Elution characteristics of vancomycin and tobramycin combined in acrylic bone–cement. J Arthroplasty. 1996;11:939–944.PubMedCrossRef Penner MJ, Masri BA, Duncan CP. Elution characteristics of vancomycin and tobramycin combined in acrylic bone–cement. J Arthroplasty. 1996;11:939–944.PubMedCrossRef
47.
go back to reference Peters G, Herrmann M, von Eiff C. The changing pattern of coagulase–negative staphylococci as infectious pathogens. Curr Opin Infect Dis. 1995;8(suppl):S12–S19.CrossRef Peters G, Herrmann M, von Eiff C. The changing pattern of coagulase–negative staphylococci as infectious pathogens. Curr Opin Infect Dis. 1995;8(suppl):S12–S19.CrossRef
48.
go back to reference Phillips JE, Crane TP, Noy M, Elliot TS, Grimer RJ. The incidence of deep prosthetic infections in a specialist orthopaedic hospital: a 15-year prospective survey. J Bone Joint Surg Br. 2006;88:943–948.PubMedCrossRef Phillips JE, Crane TP, Noy M, Elliot TS, Grimer RJ. The incidence of deep prosthetic infections in a specialist orthopaedic hospital: a 15-year prospective survey. J Bone Joint Surg Br. 2006;88:943–948.PubMedCrossRef
49.
go back to reference Pour AE, Parvizi J, Slenker N, Purtill JJ, Sharkey PF. Rotating hinged total knee replacement: use with caution. J Bone Joint Surg Am. 2007;89:1735–1741.PubMedCrossRef Pour AE, Parvizi J, Slenker N, Purtill JJ, Sharkey PF. Rotating hinged total knee replacement: use with caution. J Bone Joint Surg Am. 2007;89:1735–1741.PubMedCrossRef
50.
go back to reference Saleh KJ, Rand JA, McQueen DA. Current status of revision total knee arthroplasty: how do we assess results? J Bone Joint Surg Am. 2003;85(suppl 1):18–20. Saleh KJ, Rand JA, McQueen DA. Current status of revision total knee arthroplasty: how do we assess results? J Bone Joint Surg Am. 2003;85(suppl 1):18–20.
51.
go back to reference Schäfer P, Fink B, Sandow D, Margull A, Berger I, Frommelt L. Prolonged bacterial culture to identify late periprosthetic joint infection: a promising strategy. Clin Infect Dis. 2008;47:1403–1409.PubMedCrossRef Schäfer P, Fink B, Sandow D, Margull A, Berger I, Frommelt L. Prolonged bacterial culture to identify late periprosthetic joint infection: a promising strategy. Clin Infect Dis. 2008;47:1403–1409.PubMedCrossRef
52.
go back to reference Scuderi GR, Insall JN, Windsor RE, Moran MC. Survivorship of cemented knee replacements. J Bone Joint Surg Br. 1989;71:798–803.PubMed Scuderi GR, Insall JN, Windsor RE, Moran MC. Survivorship of cemented knee replacements. J Bone Joint Surg Br. 1989;71:798–803.PubMed
53.
go back to reference Simpson PM, Dall GF, Breusch SJ, Heisel C. [In vitro elution and mechanical properties of antibiotic-loaded SmartSet HV and Palacos R acrylic bone cements][in German]. Orthopäde. 2005;34:1255–1262.PubMedCrossRef Simpson PM, Dall GF, Breusch SJ, Heisel C. [In vitro elution and mechanical properties of antibiotic-loaded SmartSet HV and Palacos R acrylic bone cements][in German]. Orthopäde. 2005;34:1255–1262.PubMedCrossRef
54.
go back to reference Sofer D, Regenbrecht B, Pfeil J. [Early results of one-stage septic revision arthroplasties with antibiotic-laden cement: a clinical and statistical analysis][in German]. Orthopäde. 2005;34:592–602.PubMedCrossRef Sofer D, Regenbrecht B, Pfeil J. [Early results of one-stage septic revision arthroplasties with antibiotic-laden cement: a clinical and statistical analysis][in German]. Orthopäde. 2005;34:592–602.PubMedCrossRef
55.
go back to reference Steinbrink K, Frommelt L. [Treatment of periprosthetic infection of the hip using one-stage exchange surgery][in German]. Orthopäde. 1995;24:335–343.PubMed Steinbrink K, Frommelt L. [Treatment of periprosthetic infection of the hip using one-stage exchange surgery][in German]. Orthopäde. 1995;24:335–343.PubMed
56.
go back to reference Stockley I, Mockford BJ, Hoad-Reddick A, Norman P. The use of two-stage exchange arthroplasty with depot antibiotics in the absence of long-term antibiotic therapy in infected total hip replacement. J Bone Joint Surg Br. 2008;90:145–148.PubMed Stockley I, Mockford BJ, Hoad-Reddick A, Norman P. The use of two-stage exchange arthroplasty with depot antibiotics in the absence of long-term antibiotic therapy in infected total hip replacement. J Bone Joint Surg Br. 2008;90:145–148.PubMed
57.
go back to reference von Foerster G, Klüber D, Käbler U. [Mid- to long-term results after treatment of 118 cases of periprosthetic infections after knee joint replacement using one-stage exchange surgery][in German]. Orthopäde. 1991;20:244–252. von Foerster G, Klüber D, Käbler U. [Mid- to long-term results after treatment of 118 cases of periprosthetic infections after knee joint replacement using one-stage exchange surgery][in German]. Orthopäde. 1991;20:244–252.
58.
go back to reference Zimmerli W, Widmer AF, Blatter M, Frei R, Ochsner PE. Role of rifampin for treatment of orthopedic implant-related staphylococcal infections: a randomized controlled trial. Foreign-Body Infection (FBI) Study Group. JAMA. 1998;279:1537–1541.PubMedCrossRef Zimmerli W, Widmer AF, Blatter M, Frei R, Ochsner PE. Role of rifampin for treatment of orthopedic implant-related staphylococcal infections: a randomized controlled trial. Foreign-Body Infection (FBI) Study Group. JAMA. 1998;279:1537–1541.PubMedCrossRef
Metadata
Title
High Rate of Infection Control with One-stage Revision of Septic Knee Prostheses Excluding MRSA and MRSE
Authors
Joachim Singer, MD
Andreas Merz, MD
Lars Frommelt, MD
Bernd Fink, MD
Publication date
01-05-2012
Publisher
Springer-Verlag
Published in
Clinical Orthopaedics and Related Research® / Issue 5/2012
Print ISSN: 0009-921X
Electronic ISSN: 1528-1132
DOI
https://doi.org/10.1007/s11999-011-2174-6

Other articles of this Issue 5/2012

Clinical Orthopaedics and Related Research® 5/2012 Go to the issue

Symposium: Current Approaches in Cerebral Palsy, A Focus on Gait Problems

Coronal Plane Knee Moments Improve After Correcting External Tibial Torsion in Patients With Cerebral Palsy

Symposium: Current Approaches in Cerebral Palsy, A Focus on Gait Problems

Current Approaches in Cerebral Palsy, A Focus on Gait Problems: Editorial Comment

Symposium: Evolving Medicolegal Concepts

Evolving Medicolegal Concepts: Editorial Comment

Symposium: Current Approaches in Cerebral Palsy, A Focus on Gait Problems

Rectus Femoris Distal Tendon Resection Improves Knee Motion in Patients With Spastic Diplegia